BACKGROUND: @entity7667 are rare glioneuronal @entity5 that typically cause refractory @entity410 during the first 3 decades of life. OBJECTIVE: To determine the prognosticators of @entity410 outcome after surgery for @entity7667 . METHODS: We reviewed the cases of 66 @entity1 who underwent resection of @entity7667 at the University of California, San Francisco. Demographic, @entity410 history, and operative data were examined for statistical association with postoperative @entity410 outcomes. RESULTS: Of the 66 @entity1 who underwent surgical resection of @entity7667 , 49 @entity1 (74%) presented with a history of @entity410 . Of those 49 @entity1 , 50% presented with intractable @entity302 . @entity1315 were present in 76% of the @entity1 who presented with a history of @entity410 . Electrocorticography was performed on 35% of the @entity1 , and of those @entity1 , 82% underwent extended lesionectomy to remove abnormally epileptogenic extralesional tissue. The median follow-up duration was 6.9 years, during which @entity5 progression occurred in 38% of @entity1 who underwent subtotal resection and in 8% of @entity1 who underwent gross total resection (P = .02). Overall, 85% of @entity1 were @entity410 free (International League Against @entity302 class I or II) 5 years after surgery. Subtotal resection was associated with poor @entity410 outcomes 1 year after resection (odds ratio = 14.6; 95% confidence interval = 2.4-87.7): rates of @entity410 freedom were 54% after subtotal resection, 96% after gross total resection, and 93% after gross total resection with intraoperative electrocorticography-guided extended lesionectomy. CONCLUSION: We report excellent long-term @entity410 control outcomes after surgery for @entity7667 . Intraoperative electrocorticography may be a useful adjunct for guiding extended resection in certain pharmacoresistant @entity302 @entity1 with @entity7667 . Subtotal resection is associated with higher rates of @entity5 progression and nonoptimal @entity410 outcomes.

Long-term XXXX control outcomes after resection of @entity7667 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure', 'seizures'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity1315 :: ('MESH:D004833', 'Disease') :: ['Temporal lobe gangliogliomas'] @entity302 :: ('MESH:D004827', 'Disease') :: ['epilepsy', 'Epilepsy'] @entity7667 :: ('MESH:D018303', 'Disease') :: ['ganglioglioma', 'gangliogliomas', 'Gangliogliomas']
@entity410 :: (MESH:D012640,Disease) :: ['seizure']
